DE3639561A1
(de)
*
|
1986-11-20 |
1988-06-01 |
Baumann Hanno |
Verfahren zur herstellung von nicht-thrombogenen substraten
|
WO1988004183A1
(en)
*
|
1986-12-03 |
1988-06-16 |
Terumo Kabushiki Kaisha |
Antithrombotic medical materials and process for their production
|
JPS63290573A
(ja)
*
|
1987-03-13 |
1988-11-28 |
バクスター・インターナショナル・インコーポレイテッド |
ヘパリン緩放出用医療装置
|
JP2529112B2
(ja)
*
|
1987-08-31 |
1996-08-28 |
株式会社 高研 |
生体弁
|
FR2622201B1
(fr)
*
|
1987-10-23 |
1990-03-23 |
Essilor Int |
Elastomere de silicones mouillable convenant a la fabrication de lentilles de contact
|
DE3738109A1
(de)
*
|
1987-11-10 |
1989-05-18 |
Bayer Ag |
Mischungen von polycarbonaten mit siloxanhaltigen pfropfpolymerisaten
|
US5262451A
(en)
*
|
1988-06-08 |
1993-11-16 |
Cardiopulmonics, Inc. |
Multifunctional thrombo-resistant coatings and methods of manufacture
|
US5182317A
(en)
*
|
1988-06-08 |
1993-01-26 |
Cardiopulmonics, Inc. |
Multifunctional thrombo-resistant coatings and methods of manufacture
|
US5342693A
(en)
*
|
1988-06-08 |
1994-08-30 |
Cardiopulmonics, Inc. |
Multifunctional thrombo-resistant coating and methods of manufacture
|
US5338770A
(en)
*
|
1988-06-08 |
1994-08-16 |
Cardiopulmonics, Inc. |
Gas permeable thrombo-resistant coatings and methods of manufacture
|
JP2678945B2
(ja)
*
|
1989-04-17 |
1997-11-19 |
有限会社ナイセム |
人工血管とその製造方法及び人工血管用基質
|
KR920000459B1
(ko)
*
|
1989-12-13 |
1992-01-14 |
재단법인 한국화학연구소 |
다당류 유도체가 도포된 인공혈관과 그 제조방법
|
JPH0783759B2
(ja)
*
|
1990-06-29 |
1995-09-13 |
株式会社高研 |
コラーゲン繊維止血材及びその製造方法
|
US5248766A
(en)
*
|
1990-08-17 |
1993-09-28 |
Baxter International Inc. |
Oxirane-modified hemoglobin based composition
|
WO1992014419A1
(en)
*
|
1991-02-14 |
1992-09-03 |
Baxter International Inc. |
Pliable biological graft materials and their methods of manufacture
|
US5314874A
(en)
*
|
1991-04-19 |
1994-05-24 |
Koken Co., Ltd. |
Intracorporeally injectable composition for implanting highly concentrated cross-linked atelocollagen
|
SE470006B
(sv)
*
|
1991-09-26 |
1993-10-25 |
Corline Systems Ab |
Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
|
US5383927A
(en)
*
|
1992-05-07 |
1995-01-24 |
Intervascular Inc. |
Non-thromogenic vascular prosthesis
|
WO1995010989A1
(en)
*
|
1993-10-19 |
1995-04-27 |
Scimed Life Systems, Inc. |
Intravascular stent pump
|
US5545553A
(en)
*
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
US5532311A
(en)
*
|
1995-02-01 |
1996-07-02 |
Minnesota Mining And Manufacturing Company |
Process for modifying surfaces
|
JP3799626B2
(ja)
*
|
1995-04-25 |
2006-07-19 |
有限会社ナイセム |
心臓血管修復材及びその製造方法
|
US5583213A
(en)
*
|
1995-05-12 |
1996-12-10 |
Minnesota Mining And Manufacturing Company |
Process to activate sulfated polysaccharides
|
WO1996037241A1
(en)
*
|
1995-05-25 |
1996-11-28 |
Minnesota Mining And Manufacturing Company |
Process for producing biocompatible surfaces
|
EP0888142B1
(de)
*
|
1996-03-04 |
2003-05-28 |
Edwards Lifesciences Corporation |
Nichtpolymere epoxyverbindungen zur vernetzung von biologischem gewebe und daraus hergestellte bioprothesen
|
US5782931A
(en)
*
|
1996-07-30 |
1998-07-21 |
Baxter International Inc. |
Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
|
US6624138B1
(en)
|
2001-09-27 |
2003-09-23 |
Gp Medical |
Drug-loaded biological material chemically treated with genipin
|
US7351421B2
(en)
*
|
1996-11-05 |
2008-04-01 |
Hsing-Wen Sung |
Drug-eluting stent having collagen drug carrier chemically treated with genipin
|
US7101857B2
(en)
*
|
1996-11-05 |
2006-09-05 |
Gp Medical, Inc. |
Crosslinkable biological material and medical uses
|
US6545042B2
(en)
|
1996-11-05 |
2003-04-08 |
Gp Medical |
Acellular biological material chemically treated with genipin
|
US7282220B1
(en)
|
1996-11-05 |
2007-10-16 |
Hsing-Wen Sung |
Genipin-crosslinked gelatin microspheres as drug carrier
|
US20050163818A1
(en)
*
|
1996-11-05 |
2005-07-28 |
Hsing-Wen Sung |
Drug-eluting device chemically treated with genipin
|
US6998418B1
(en)
|
1996-11-05 |
2006-02-14 |
Gp Medical, Inc. |
Acellular biological material chemically treated with genipin
|
US5891196A
(en)
*
|
1997-04-16 |
1999-04-06 |
Baxter International Inc. |
Method for actively binding heparin to crosslinked biological tissues
|
US6197289B1
(en)
|
1997-07-01 |
2001-03-06 |
Terumo Cardiovascular Systems Corporation |
Removal of biologically active agents
|
US6146771A
(en)
*
|
1997-07-01 |
2000-11-14 |
Terumo Cardiovascular Systems Corporation |
Process for modifying surfaces using the reaction product of a water-insoluble polymer and a polyalkylene imine
|
US6117979A
(en)
*
|
1997-08-18 |
2000-09-12 |
Medtronic, Inc. |
Process for making a bioprosthetic device and implants produced therefrom
|
US6166184A
(en)
*
|
1997-08-18 |
2000-12-26 |
Medtronic Inc. |
Process for making a bioprosthetic device
|
US6254564B1
(en)
|
1998-09-10 |
2001-07-03 |
Percardia, Inc. |
Left ventricular conduit with blood vessel graft
|
US6106555A
(en)
*
|
1998-12-15 |
2000-08-22 |
Av Healing Llc |
Method for tissue fixation
|
US6521284B1
(en)
|
1999-11-03 |
2003-02-18 |
Scimed Life Systems, Inc. |
Process for impregnating a porous material with a cross-linkable composition
|
US6506398B1
(en)
*
|
2000-04-28 |
2003-01-14 |
Hosheng Tu |
Device for treating diabetes and methods thereof
|
US6506437B1
(en)
*
|
2000-10-17 |
2003-01-14 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device having depots formed in a surface thereof
|
DE10060660A1
(de)
*
|
2000-12-06 |
2002-06-20 |
Frey Rainer |
Verfahren zur Konservierung von biologischen Prothesen, konservierte biologische Prothese und Konservierungslösung
|
KR100514582B1
(ko)
*
|
2001-09-05 |
2005-09-13 |
한스바이오메드 주식회사 |
생체복원물질의 제조방법
|
US7226903B2
(en)
*
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
ES2516041T3
(es)
|
2001-10-10 |
2014-10-30 |
Ratiopharm Gmbh |
Remodelación y glicoconjugación de la hormona del crecimiento humano (hGH)
|
US7157277B2
(en)
*
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US7439043B2
(en)
*
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
US7265085B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
US7265084B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7696163B2
(en)
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7795210B2
(en)
*
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US8008252B2
(en)
*
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
EP2305311A3
(de)
|
2001-10-10 |
2011-07-20 |
BioGeneriX AG |
Glykokonjugation von Peptiden
|
US7125843B2
(en)
*
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
US7399613B2
(en)
*
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7173003B2
(en)
*
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7297511B2
(en)
*
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
US7473680B2
(en)
*
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
US20050171616A1
(en)
*
|
2002-02-04 |
2005-08-04 |
Hsing-Wen Sung |
Peritoneal regeneration with acellular pericardial patch
|
DE60336555D1
(de)
*
|
2002-06-21 |
2011-05-12 |
Novo Nordisk Healthcare Ag |
Pegylierte glykoformen von faktor vii
|
US20050019404A1
(en)
*
|
2003-06-30 |
2005-01-27 |
Hsing-Wen Sung |
Drug-eluting biodegradable stent
|
US20050163821A1
(en)
*
|
2002-08-02 |
2005-07-28 |
Hsing-Wen Sung |
Drug-eluting Biodegradable Stent and Delivery Means
|
US7060684B1
(en)
|
2002-12-16 |
2006-06-13 |
Quijano Rodolfo C |
Device for treating diabetes and methods thereof
|
KR20060003862A
(ko)
*
|
2003-03-14 |
2006-01-11 |
네오스 테크놀로지스, 인크. |
수용성분기폴리머 및 그 접합체
|
MXPA05010773A
(es)
|
2003-04-09 |
2005-12-12 |
Neose Technologies Inc |
Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos.
|
EP1613261A4
(de)
*
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
Intrazelluläre bildung von peptidkonjugaten
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
US7159593B2
(en)
*
|
2003-04-17 |
2007-01-09 |
3F Therapeutics, Inc. |
Methods for reduction of pressure effects of cardiac tricuspid valve regurgitation
|
US7530995B2
(en)
*
|
2003-04-17 |
2009-05-12 |
3F Therapeutics, Inc. |
Device for reduction of pressure effects of cardiac tricuspid valve regurgitation
|
EP1624847B1
(de)
|
2003-05-09 |
2012-01-04 |
BioGeneriX AG |
Zusammensetzungen und Verfahren zur Herstellung von Glykosylierungsmutanten des menschlichen Wachstumshormons
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
US20050049692A1
(en)
*
|
2003-09-02 |
2005-03-03 |
Numamoto Michael J. |
Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation
|
AU2004293103C1
(en)
*
|
2003-11-24 |
2010-12-02 |
Ratiopharm Gmbh |
Glycopegylated erythropoietin
|
US7842661B2
(en)
*
|
2003-11-24 |
2010-11-30 |
Novo Nordisk A/S |
Glycopegylated erythropoietin formulations
|
US8633157B2
(en)
*
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US20080305992A1
(en)
*
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US20060040856A1
(en)
*
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
US20080318850A1
(en)
*
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
KR101237884B1
(ko)
*
|
2003-12-03 |
2013-02-27 |
바이오제너릭스 에이지 |
글리코 peg화 과립구 콜로니 자극인자
|
BRPI0506741A
(pt)
*
|
2004-01-08 |
2007-05-15 |
Neose Technologies Inc |
glicosilação de peptìdeos ligados a o
|
WO2005096988A1
(en)
*
|
2004-04-01 |
2005-10-20 |
Cook Incorporated |
A device for retracting the walls of a body vessel with remodelable material
|
BRPI0510295A
(pt)
|
2004-05-04 |
2007-11-06 |
Novo Nordisk Healthcare Ag |
preparação de uma glicoproteìna, e, método para produzir a mesma
|
US20080300173A1
(en)
|
2004-07-13 |
2008-12-04 |
Defrees Shawn |
Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
|
US8268967B2
(en)
*
|
2004-09-10 |
2012-09-18 |
Novo Nordisk A/S |
Glycopegylated interferon α
|
EP1797192A1
(de)
*
|
2004-09-29 |
2007-06-20 |
Novo Nordisk Health Care AG |
Modifizierte proteine
|
JP5948627B2
(ja)
|
2004-10-29 |
2016-07-20 |
レイショファーム ゲーエムベーハー |
線維芽細胞成長因子(fgf)のリモデリングと糖質ペグ化
|
JP2008526864A
(ja)
*
|
2005-01-06 |
2008-07-24 |
ネオス テクノロジーズ インコーポレイテッド |
糖断片を用いる糖結合
|
EP1858543B1
(de)
*
|
2005-01-10 |
2013-11-27 |
BioGeneriX AG |
Glycopegylierten Granulocyten-Kolonie-stimulierender Faktor
|
DE102005003632A1
(de)
|
2005-01-20 |
2006-08-17 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Katheter für die transvaskuläre Implantation von Herzklappenprothesen
|
WO2006105426A2
(en)
*
|
2005-03-30 |
2006-10-05 |
Neose Technologies, Inc. |
Manufacturing process for the production of peptides grown in insect cell lines
|
US8197534B2
(en)
|
2005-03-31 |
2012-06-12 |
Cook Medical Technologies Llc |
Valve device with inflatable chamber
|
US20070154992A1
(en)
*
|
2005-04-08 |
2007-07-05 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
JP5216580B2
(ja)
|
2005-05-25 |
2013-06-19 |
ノヴォ ノルディスク アー/エス |
グリコペグ化第ix因子
|
JP2009515508A
(ja)
*
|
2005-08-19 |
2009-04-16 |
ネオス テクノロジーズ インコーポレイテッド |
グリコpeg化因子viiおよび因子viia
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
US20090048440A1
(en)
*
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
US8557601B2
(en)
|
2006-07-10 |
2013-10-15 |
The Regents Of The University Of California |
Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
|
CN101516388B
(zh)
*
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
EP2054521A4
(de)
*
|
2006-10-03 |
2012-12-19 |
Novo Nordisk As |
Verfahren zur reinigung von polypeptid-konjugate
|
KR101556248B1
(ko)
*
|
2006-10-04 |
2015-09-30 |
노보 노르디스크 에이/에스 |
글리세롤이 연결된 페길화된 당 및 글리코펩티드
|
WO2008073620A2
(en)
*
|
2006-11-02 |
2008-06-19 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
US20080195230A1
(en)
*
|
2007-02-09 |
2008-08-14 |
Quijano Rodolfo C |
Pericardial tissue sheet
|
US20080195229A1
(en)
*
|
2007-02-09 |
2008-08-14 |
Quijano Rodolfo C |
Decellularized pericardial tissue
|
RS52845B
(en)
*
|
2007-04-03 |
2013-12-31 |
Biogenerix Ag |
TREATMENT PROCEDURES USING GLYCOPEGILATED G-CSF
|
US7896915B2
(en)
|
2007-04-13 |
2011-03-01 |
Jenavalve Technology, Inc. |
Medical device for treating a heart valve insufficiency
|
US20090053167A1
(en)
*
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
JP2010531135A
(ja)
*
|
2007-06-04 |
2010-09-24 |
ノボ ノルディスク アクティーゼルスカブ |
N−アセチルグルコサミニルトランスフェラーゼを使用したo結合型グリコシル化
|
US9493499B2
(en)
*
|
2007-06-12 |
2016-11-15 |
Novo Nordisk A/S |
Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
|
US8207112B2
(en)
*
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
US8414872B2
(en)
|
2007-09-10 |
2013-04-09 |
Liquid Keratin, Inc. |
Hair straightening formulations, methods and systems
|
US7846199B2
(en)
*
|
2007-11-19 |
2010-12-07 |
Cook Incorporated |
Remodelable prosthetic valve
|
JP5647899B2
(ja)
*
|
2008-01-08 |
2015-01-07 |
ラツィオファルム ゲーエムベーハーratiopharm GmbH |
オリゴサッカリルトランスフェラーゼを使用するポリペプチドの複合糖質化
|
EP2695587A1
(de)
|
2008-01-25 |
2014-02-12 |
JenaValve Technology Inc. |
Medizinisches Gerät für die therapeutische Behandlung von Herzklappeninsuffizienz
|
US9044318B2
(en)
|
2008-02-26 |
2015-06-02 |
Jenavalve Technology Gmbh |
Stent for the positioning and anchoring of a valvular prosthesis
|
WO2011104269A1
(en)
|
2008-02-26 |
2011-09-01 |
Jenavalve Technology Inc. |
Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
|
EP2257311B1
(de)
|
2008-02-27 |
2014-04-16 |
Novo Nordisk A/S |
Konjugierte faktor-viii-moleküle
|
WO2011147849A1
(en)
|
2010-05-25 |
2011-12-01 |
Jenavalve Technology Inc. |
Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
|
WO2012140676A2
(en)
|
2011-04-12 |
2012-10-18 |
Appaiah C B |
Chimeric antibacterial polypeptides
|
ES2561094T3
(es)
|
2011-07-28 |
2016-02-24 |
Harbor Medtech, Inc. |
Productos de tejidos reticulados humanos o animales y sus métodos de fabricación y uso
|
EP3281608B1
(de)
|
2012-02-10 |
2020-09-16 |
CVDevices, LLC |
Produit medical contenant une armature et plèvre viscérale
|
EP2953580A2
(de)
|
2013-02-11 |
2015-12-16 |
Cook Medical Technologies LLC |
Expandierbarer stützrahmen und medizinische vorrichtung
|
US11033640B2
(en)
|
2013-03-15 |
2021-06-15 |
The Regents Of The University Of California |
Enteric CT contrast material based on low-z atoms
|
JP2016528259A
(ja)
|
2013-08-16 |
2016-09-15 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
シリコーン系腸管ct造影材料
|
JP6563394B2
(ja)
|
2013-08-30 |
2019-08-21 |
イェーナヴァルヴ テクノロジー インコーポレイテッド |
人工弁のための径方向に折り畳み自在のフレーム及び当該フレームを製造するための方法
|
JP6173277B2
(ja)
*
|
2014-08-27 |
2017-08-02 |
泰晴 野一色 |
人工血管及びその製造方法
|
WO2016177562A1
(en)
|
2015-05-01 |
2016-11-10 |
Jenavalve Technology, Inc. |
Device and method with reduced pacemaker rate in heart valve replacement
|
EP4183371A1
(de)
|
2016-05-13 |
2023-05-24 |
JenaValve Technology, Inc. |
Herzklappenprotheseneinführungssystem und verfahren zur einführung einer herzklappenprothese mit einführschleuse und ladesystem
|
WO2018138658A1
(en)
|
2017-01-27 |
2018-08-02 |
Jenavalve Technology, Inc. |
Heart valve mimicry
|
WO2021199950A1
(ja)
*
|
2020-03-31 |
2021-10-07 |
テルモ株式会社 |
人工血管および人工血管の製造方法
|